TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ≥2 Years of Follow-Up.

Thomas Powles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.